Serum hepcidin and paraoxonase levels in patients with severe, moderate, and mild obstructive sleep apnea hypopnea syndrome (OSAS): A comparison between OSAS patients and simple snoring patients.

Umit KucuktepeÖmer Tarık SelçukHamit Yasar EllidagDogukan Aydenizoz Nursel Turkoglu Selcuk Hulya EyigorLevent RendaUstun OsmaMustafa Deniz Yilmaz

Published in: Cranio : the journal of craniomandibular practice (2022)

A significant difference was found between the OSAS groups with respect to paraoxonase enzyme, and a negative correlation with AHI was observed. Paraoxonase level could be used as a biomarker in OSAS. No significant data was found for hepcidin levels; therefore, hepcidin cannot be used as a biomarker in OSAS.

Keyphrases

obstructive sleep apnea
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
positive airway pressure
machine learning
early onset
patient reported outcomes
high intensity
case report
big data
patient reported